News
STXS
1.740
-3.33%
-0.060
Press Release: Stereotaxis Completes Acquisition of Robocath
Dow Jones · 6h ago
Weekly Report: what happened at STXS last week (0629-0703)?
Weekly Report · 3d ago
Stereotaxis management to meet with BTIG
TipRanks · 07/01 20:10
Weekly Report: what happened at STXS last week (0622-0626)?
Weekly Report · 06/29 09:37
Weekly Report: what happened at STXS last week (0615-0619)?
Weekly Report · 06/22 09:41
Weekly Report: what happened at STXS last week (0608-0612)?
Weekly Report · 06/15 09:42
Weekly Report: what happened at STXS last week (0601-0605)?
Weekly Report · 06/08 09:40
Weekly Report: what happened at STXS last week (0525-0529)?
Weekly Report · 06/01 09:42
ISRG's Ion Platform: A Major Growth Engine in Lung Cancer Care?
NASDAQ · 05/25 15:16
Weekly Report: what happened at STXS last week (0518-0522)?
Weekly Report · 05/25 09:44
Stereotaxis Charts Bold Robotics Pivot Amid Strain
TipRanks · 05/20 03:37
Weekly Report: what happened at STXS last week (0511-0515)?
Weekly Report · 05/18 09:44
Stereotaxis Q1 Earnings Call Highlights
Barchart · 05/15 21:05
Stereotaxis Shareholders Endorse Board, Auditor and Compensation
TipRanks · 05/15 19:59
Stereotaxis Earnings Call: High Potential, Tight Runway
TipRanks · 05/14 00:20
Stereotaxis Price Target Cut to $3.50/Share From $4.00 by Piper Sandler
Dow Jones · 05/13 13:22
Lake Street Keeps Their Buy Rating on Stereotaxis (STXS)
TipRanks · 05/13 13:17
Piper Sandler Reiterates Overweight on Stereotaxis, Lowers Price Target to $3.5
Benzinga · 05/13 13:12
Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Neurogene (NGNE) and Stereotaxis (STXS)
TipRanks · 05/13 12:00
Piper Sandler Remains a Buy on Stereotaxis (STXS)
TipRanks · 05/13 11:16
More
Webull provides a variety of real-time STXS stock news. You can receive the latest news about Stereotaxis Ord through multiple platforms. This information may help you make smarter investment decisions.
About STXS
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.